Loading...
Publication: Should baricitinib be used to treat COVID-19?
Parrish, A Reubenson, G Blockman, M Cohen, K Gray, A Kredo, T De Waal, R Nel, J Rees, H
Parrish, A
Reubenson, G
Blockman, M
Cohen, K
Gray, A
Kredo, T
De Waal, R
Nel, J
Rees, H
Citations
Altmetric:
Abstract
Description
This rapid review reports the available evidence about the benefits and harms of baricitinib for treating
patients aged 18 years and older hospitalised with COVID-19.
Date
2021-11-19
Journal Title
Journal ISSN
Volume Title
Publisher
South African National Department of Health
Collections
Research Projects
Organizational Units
Journal Issue
Keywords
Rapid review,Hospitalised COVID-19 patients,Janus kinase inhibitor,Guidelines,SARS-CoV-2,Baricitinib